Guillain-Barré Syndrome (GBS) Drug Development Pipeline Research Report 2025 Featuring Annexon and Hansa Biopharma

Yahoo FinanceMar 4 10:51 ET

Jefferies Maintains Annexon(ANNX.US) With Buy Rating, Raises Target Price to $10

Moomoo NewsMar 4 09:31 ET · Ratings

Promising Developments in Annexon Biosciences' Pipeline Drive Buy Rating

TipRanksMar 4 08:38 ET · Ratings

H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Cuts Target Price to $20

Moomoo NewsMar 4 08:33 ET · Ratings

Annexon Price Target Lowered to $20 From $30 at H.C. Wainwright

TipRanksMar 4 08:11 ET

Needham Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsMar 4 07:34 ET · Ratings